ENPP2 and cardiovascular disorder: In pathophysiology, ATX-LPA signalling has been implicated in tumour progression, pulmonary fibrosis, neuropathic pain, cardiovascular disease and cholestatic pruritus, making the ATX-LPA signalling axis an attractive therapeutic target7.